SOD1 lactylation impair its enzymatic activity by conformational change to aggravate intervertebral disc degeneration.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41764208.
- Also identified by DOI 10.1038/s41467-026-69127-3 and PMC identifier 13066621.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lactate accumulation is a hallmark and contributing factor of intervertebral disc degeneration (IVDD), while the role of protein lactylation caused by lactate accumulation in IVDD remains unclear. Via metabolomics, single-cell RNA-sequencing analysis, and lactylation proteomics, we reveal the lactylome landscape in IVDD and identified superoxide dismutase 1 (SOD1) lactylation at lysine 123 (SOD1<sup>K123la</sup>) as crucial for IVDD aggravation. Using in vitro site-directed mutagenesis, in vivo generation of SOD1<sup>K123R</sup> mutant male rats, and in silico molecular dynamics simulations, we find that SOD1<sup>K123la</sup> alters SOD1 conformation and impairs its enzymatic activity, and induces oxidative damage, and activates p53 pathway in nucleus pulposus cells (NPCs). Notably, we identify a small molecule ZL-01 that inhibits SOD1<sup>K123la</sup>. NPC-targeted delivery of ZL-01 via collagen type II-targeted peptide-modified extracellular vesicles alleviated IVDD in male rats. Together, these findings clarify the mechanism by which SOD1<sup>K123la</sup> promotes IVDD aggravation and provide a promising therapeutic strategy for IVDD.
Medical subject headings
- Intervertebral Disc Degeneration
- Superoxide Dismutase-1